Moderna stock was slumping Thursday after it announced a major pullback in its research and development efforts, as the ...
Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.
days after new mRNA coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna started hitting pharmacies. Health officials encourage annual vaccination against the coronavirus, similar to ...
Similarly, Moderna CEO Stephane Bancel said back at the start of the pandemic that “there is no world, I think, where we would contemplate to price [the Covid-19 vaccine] higher than other ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Pfizer and Moderna's updated COVID-19 vaccines amid a summer wave of "very high" coronavirus levels in wastewater, according to the ...
as the Massachusetts firm announced the first patient had been tested with its potential coronavirus vaccine. Moderna is focused on development of vaccines based around mRNA, which present ...
The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna the OK on their shots, though all drugmakers say their shots will be ...
The Food and Drug Administration on Thursday approved the new Covid vaccines from Pfizer and Moderna. It’s the third time the vaccines have been updated to match circulating strains since the ...
The FDA has approved an updated COVID ... CEO of Immunize.org, which advocates for vaccination. People who pay out-of-pocket at pharmacies face higher prices: CVS plans to sell the updated vaccine ...
None of us want to think about it but the statistics are undeniable that cases of COVID-19 are on the rise ... should take the updated Pfizer or Moderna vaccine; those four and under may need ...
In the case of the mRNA vaccines manufactured by Pfizer and Moderna to fight COVID-19, the mRNA helps a human's cells fight the SARS-CoV-2 virus through their spike proteins. The spike proteins ...
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully ...